Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Antonio Di Garbo"'
Autor:
Pietro Giorgio Pistono, Morena Martorana, Lidia Allegramente, Maria Grazia Milia, Antonio Di Garbo, Vincenzo Bossi, Maria Teresa Granito, Paola Russo, Francesca Piro
Publikováno v:
Microbiologia Medica, Vol 21, Iss 2 (2006)
The report is an overview of enterovirus epidemiology in Piemonte during a 5-year period from 2000 to 2004 with an investigative protocol recording epidemiologic, clinical, and laboratory data. A total of 1232 clinical cerebrospinal fluid (CSF) were
Externí odkaz:
https://doaj.org/article/ed7aa92c7a1147d1b7f9a3fdaeb43b6f
Autor:
Mauro Sciandra, Lorena Baietto, Daniel Gonzalez de Requena, Antonio D'Avolio, Silvia Garazzino, Stefano Bonora, L. Trentini, Giovanni Di Perri, Silvia Fontana, Marco Siccardi, Maria Grazia Milia, Antonio Di Garbo, Andrea Calcagno
Publikováno v:
Antimicrobial agents and chemotherapy. 52(3)
Tipranavir (TPV) is a nonpeptidic protease inhibitor with potent in vitro activity against most human immunodeficiency virus (HIV) type 1 (HIV-1) strains resistant to other protease inhibitors (PIs) (1, 14, 15). In vitro data have shown that resistan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc9f8c1f5e64fb9236bd29cdbd94f1a8
https://pubmed.ncbi.nlm.nih.gov/18160524
https://pubmed.ncbi.nlm.nih.gov/18160524
Autor:
Francesca Piro, Pietro Giorgio Pistono, Vincenzo Bossi, Morena Martorana, Maria Teresa Granito, Paola Russo, Maria Grazia Milia, Lidia Allegramente, Antonio Di Garbo
Publikováno v:
Microbiologia Medica, Vol 20, Iss 3 (2005)
The report is an overview of enterovirus epidemiology in Piemonte during a 5-year period from 2000 to 2004 with an investigative protocol recording epidemiologic, clinical, and laboratory data. A total of 1232 clinical cerebrospinal fluid (CSF) were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::427c2756eed95c9255e82a2ca12ca538
http://www.pagepressjournals.org/index.php/mm/article/view/3640
http://www.pagepressjournals.org/index.php/mm/article/view/3640
Autor:
David Back, Patrick G. Hoggard, Stefano Bonora, Helen Reynolds, Riccardo Raiteri, Alessandro Sinicco, Isabella Arnaudo, Marta Boffito, Giovanni Di Perri, Antonio Di Garbo
Lopinavir/ritonavir was administered to 35 HIV-infected patients after therapeutic failure with other protease inhibitors. The pharmacokinetics (trough concentrations) and baseline viral genotype were determined, together with the immunovirological o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6e5e0a4c18629b94f3cb984bdbe1b55
http://hdl.handle.net/2318/40756
http://hdl.handle.net/2318/40756
